Release Date: 26/11/13 19:50 Summary: Appendix 3B - Issue of Options Price Sensitive: No Download Document 134.08KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%